Egypt registers 227 new coronavirus cases, 11 fatalities



Wed, 11 Nov 2020 - 10:25 GMT


Wed, 11 Nov 2020 - 10:25 GMT

FILE - Test tube with Coronavirus name label is seen in this illustration – Reuters

FILE - Test tube with Coronavirus name label is seen in this illustration – Reuters

CAIRO - 11 November 2020: The Ministry of Health announced on Wednesday that 227 new coronavirus cases were detected, upping the total number of confirmed cases in the country to 109,881.

In a statement, Spokesman for the Health Ministry Khaled Megahed said 11 patients have died from the virus over the past 24 hours, raising the overall death toll to 6,405 since the outset of the pandemic.

As many as 97 patients were discharged from isolation hospitals after receiving necessary medical care, taking the number of recovered cases so far to 100,439, the spokesman said. 


The ministry announced Tuesday that it had reserved Pfizer anti-COVID-19 vaccine doses that will fulfill 20 percent of Egypt's needs.


Hopes are soaring that a Covid vaccine is within reach, following news that an interim analysis has shown Pfizer/BioNTech’s candidate was 90% effective in protecting people from transmission of the virus in global trials.


The vaccine performed much better than most experts had hoped for, according to the companies’ analysis, and brings into view a potential end to a pandemic that has killed more than a million people, battered economies and upended daily life worldwide, The Guardian reported Monday.


The data is from an interim analysis and the trial continues into December but the headline results were emphatic. Regulators will be looking to process an emergency licence application at record speed.


Manufacturing is already under way. Pfizer said they expect to supply globally up to 50m vaccine doses in 2020 and up to 1.3bn doses in 2021.


“Today is a great day for science and humanity. The first set of results from our phase 3 Covid-19 vaccine trial provides the initial evidence of our vaccine’s ability to prevent Covid-19,” said Dr Albert Bourla, the Pfizer chairman and chief executive.


“We are reaching this critical milestone in our vaccine development program at a time when the world needs it most with infection rates setting new records, hospitals nearing over-capacity and economies struggling to reopen.”


Additional reporting by MENA



Leave a Comment

Be Social